Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
View Patent ↗This invention is directed to a pharmaceutical composition comprising the sodium-hydrogen exchanger (NHE) inhibitor cariporide and an angiotensin converting enzyme (ACE) inhibitor which exhibits unexpectedly efficacious properties for preventing heart failure and other age-related organ dysfunctions, age-related disorders and for prolonging life, and to methods of preventing heart failure and other age-related organ dysfunctions, age-related disorders and for prolonging life comprising administering pharmaceutically effective amounts of the sodium-hydrogen exchange inhibitor cariporide and an ACE inhibitor.
1. A pharmaceutical composition comprising (a) a pharmaceutically effective amount of cariporide and (b) ramipril, at an amount of ramipril that if administered alone, does not affect the blood pressure, wherein said cariporide and ramipril are in relative amounts that produce a synergistic effect in life prolongation and inhibition of organ damage.
2. A pharmaceutical composition of claim 1 , having a ratio by weight of cariporide to ramipril that lies in the range between 1:0.0001 and 1:1.
3. A pharmaceutical composition of claim 2 , having a ratio by weight of cariporide to ramipril that lies in the range between 1:0.0001 and 1:0.1.
4. A pharmaceutical composition of claim 3 , having a ratio by weight of cariporide to ramipril that lies in the range between 1:0.0005 and 1:0.01.